Michael B. Clearfield. Weight of the Evidence in Statin Clinical Trials: Comparing the Results. J Am Osteopath Assoc 2003;103(7_suppl_3):S4–S11. doi: .
Download citation file:
This review of lipid-lowering trials looks at both the primary and secondary prevention of coronary heart disease. It also introduces evidence pointing toward the emerging importance of nonlipid risk factors in the pathogenesis of atherosclerosis. This review is designed to enhance the primary care physician's working knowledge of the evidence supporting the importance of LDL-C reduction and the central role of statin therapy in the reduction of the risk of coronary heart disease, as well as provide a greater understanding of emerging risk factors.
This PDF is available to Subscribers Only
View Article Abstract & Purchase Options